Invention Grant
- Patent Title: Sphingosine pathway modulating compounds for the treatment of coronavirus infection
-
Application No.: US17197105Application Date: 2021-03-10
-
Publication No.: US11554111B2Publication Date: 2023-01-17
- Inventor: Elazar Rabbani
- Applicant: Enzo Biochem, Inc.
- Applicant Address: US NY New York
- Assignee: Enzo Biochem, Inc.
- Current Assignee: Enzo Biochem, Inc.
- Current Assignee Address: US NY New York
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61K31/137
Abstract:
The invention provides methods and compositions for treating a coronavirus infection using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.
Public/Granted literature
- US20210290600A1 Sphingosine Pathway Modulating Compounds For The Treatment Of Coronavirus Infection Public/Granted day:2021-09-23
Information query
